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 A recent case-control study implied an inverse correlation between the measured body
burden of dioxins (polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans,
PCDD/F) and the risk of soft tissue sarcoma in normal population exposed to dioxins
mainly via food. The surprising result could not be explained by biases or confounding.
There is no a priori confounding by occupational chemicals in a random sample from gen-
eral population, but exposures to other lipid soluble chemicals with similar sources might
be expected to associate with that of dioxins. One such group is polychlorinated biphenyls
(PCB). Therefore three most relevant dioxin-like PCB compounds PCB 77, PCB 126, and
PCB 169 were now analyzed from the same patients. Cases were 110 soft-tissue sarcoma
patients undergoing surgery for their disease, and referents were 227 patients operated
for appendicitis. Dioxin and PCB concentrations were analyzed from subcutaneous fat
samples by high-resolution gas chromatography–mass spectrometry and TCDD equivalent
concentrations (WHO-TEq) were calculated by using toxicity equivalency factors of WHO.
The highest risk of sarcoma was found in the septile with the lowest body burden of sum
WHO-TEq, and the differences of septiles 2 and 6 from septile 1 were statistically signifi-
cant. If soft sarcoma risk is true at high occupational levels of dioxins, the provocative
result suggests that a possibility of a J-shaped dose-response curve should be taken into
consideration and studied further. This is also supported by the similar J-shaped dose
responses in animal studies.
Address correspondence to Jouko Tuomisto, National Public Health Institute, P.O. Box
95, FIN-70701 Kuopio, Finland. E-mail: jouko.tuomisto@ktl.fi.
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Abbreviations: STS, soft tissue sarcoma; IARC, International Agency of Research on Cancer; TCDD,
2,3,7,8-tetrachlorodibenzo-p-dioxin; PCDD/Fs, polychlorinated dibenzo-p-dioxins and dibenzofurans;
in congener nomenclature: T=tetra, Pe=penta, Hx=hexa, Hp=hepta, O=octa, CDD=chlorinated
dibenzo-p-dioxin, CDF=chlorinated dibenzofuran; PCBs, polychlorinated biphenyls, TEF, toxic equiv-
alency factor; WHO-TEq, toxic equivalencies according to World Health Organization (WHO).
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INTRODUCTION
There has been a continuous search for a “physiological” function of AH
receptor (dioxin receptor) (Poellinger, 2000). In this discussion the fact that
induction of metabolism of foreign substances via AH receptor is a physiological
function, has been less often emphasized. A physiological function means implic-
itly that at some level of activation, the action of AH receptor is useful as a
response to environmental stimuli. In fact it would be strange that a highly con-
served gene (Hahn, 2002) would have been maintained, unless the function is
useful or even a necessity for life.
On the other hand it is clear that dioxin-like compounds cause a plethora of
adverse effects at high dose levels (for a review, see Pohjanvirta and Tuomisto,
1994). Most of these are AH receptor-dependent and they include various develop-
mental effects (Abbot and Birnbaum, 1989, 1990, Alaluusua et al., 1993, Kattainen
et al., 2001, Mably et al., 1992), thymic atrophy and immunological effects
(Kerkvliet et al., 1990), various hyperplastic/metaplastic effects (Poland and
Knutson 1982) and cancer (Kociba et al., 1978). In humans several effects have
been seen after high accidental or occupational doses, e.g. chloracne and pigmen-
tation (Sweeney and Mocarelli 2000, Geusau et al., 2001), several developmental
effects such as growth retardation, hyperpigmentation, neurobehavioural changes,
and alterations of sexual development after intrauterine exposure (Rogan et al.,
1988, Masuda et al., 1996, Feeley and Brouwer 2000) and tooth deformities after
accidental exposure during childhood (Alaluusua et al., 2004). A modest increase
in total cancer is suggested by occupational cohort studies (Kogevinas 2000).
Increases of gastrointestinal and hematopoietic malignancies have been seen after
a TCDD release accident in Seveso, Italy  (Bertazzi et al., 1997, 2001). Soft-tissue sar-
coma was increased toward the high end of occupational exposures in a large indus-
trial cohort (Fingerhut et al., 1991, Steenland et al., 1999).
Previous cancer studies suffer from poor exposure assessment. In most stud-
ies exposure information is based on indirect methods such as work histories,
sometimes supported by chemical analyses in part of the studied population and
modeling, or in many cases on questionnaire information. Therefore we recently
undertook a major attempt of studying soft tissue sarcoma risk in general popu-
lation in correlation to dioxin concentrations (Tuomisto et al., 2004). Sarcoma
patients coming to surgery for their tumor were analyzed for their dioxin con-
centrations, and in a case-control setting appendicitis patients were studied as ref-
erents. A surgical patient control group was needed, because dioxin analysis was
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from a subcutaneous fat sample. Among the general population in Finland the
variation in dioxin concentrations is very large, because the dominant source of
dioxins is fish, and fish consumption varies widely in the population. In this study
no positive correlation was seen between the dioxin concentrations and soft tissue
sarcoma risk, on the contrary, sarcoma risk was highest among those having the
lowest dioxin level.
Now three PCB congeners contributing most to the dioxin equivalents have
been analyzed in addition to the 17 PCDD/F congeners, and we are able to pres-
ent data on these congeners added to the total burden of dioxins.
MATERIALS AND METHODS
A detailed description of the methods was given in the previous paper (Tuomisto
et al., 2004). Therefore only the most pertinent details are shortly described here.
Study population
Most sarcoma patients in southern Finland are treated by the multidiscipli-
nary sarcoma group of Helsinki University Hospital, and the rest in the
University Hospitals of Kuopio, Turku, or Tampere. All patients over 15 years of
age referred to these hospitals for operative treatment of STS between June 1997
and December 1999 were eligible as cases. Patients over 15 years of age, operat-
ed due to an appendicitis diagnosis in any study hospital were eligible as controls.
They were collected from the same catchment area as the STS patients. Southern
Finland was divided into 15 areas, and one hospital performing appendectomy
operations was recruited to the study from each area (in Helsinki, two hospitals).
Informed consent was obtained from all patients in writing before the oper-
ation. The study was duly approved by the Ethics Committees. The total number
of patients recruited during the fieldwork was 972, and after exclusion of some
patients for technical reasons (see Tuomisto et al., 2004), 954 patients (148 cases
and 806 controls) were available for matching.
The cases and controls were individually matched for area and age at the end
of the fieldwork. Area was defined as the area of residence of the patient using
the 15 areas above. The age was determined at the day of operation. Maximum
allowed age difference between cases and controls was ±3 years, if case was <38.0
years old, and  ±6 years, if case was >38.0 years old. The control closest by age was
matched to the case. Cases with fewer controls had a priority over cases with
more controls. The number of controls per case was limited to three. For 110
cases 227 matching controls could be found in the pool. Thirty-nine cases had
one control, 25 cases had two, and 46 cases had three controls.
Exposure assessment
A subcutaneous fat sample of the matched 337 patients, obtained during an
appendectomy or sarcoma operation, was analyzed for the 17 toxic polychlori-
nated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs) and three dioxin-like
non-ortho polychlorinated biphenyls: PCB 77 (3,3′,4,4′-tetrachlorobiphenyl),
PCB 126 (3,3′,4,4′,5-pentachlorobiphenyl), and PCB 169 (3,3′,4,4′,5,5′-
hexachlorobiphenyl). Measurements were done by gas chromatography – mass
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spectrometry (Vartiainen et al., 1997) at the Laboratory of Chemistry, which is
an accredited testing laboratory (T077) for the analysis of dioxins in human sam-
ples (current standard: EN ISO/IEC 17025) and has successfully participated in
WHO/Euro intercalibrations. The concentrations were summed up after the
value of each congener was multiplied by its relative toxic potency (toxic equiva-
lency factor, TEF). The TEF values according to WHO (Van den Berg et al.,
1998) were used, resulting in toxic equivalent concentrations (WHO-TEq) com-
prising 17 PCDD/Fs and 3 PCBs. All analytical work was performed blind so that
the chemistry laboratory did not know the diagnosis of the patient. Strict quali-
ty assurance measures were undertaken.
Patients were also asked detailed questionnaire information about socio-eco-
nomic and lifestyle factors and chemical exposures. Of the matched subjects, 84
cases (76 %) and 185 controls (81 %) have also questionnaire information. 
Statistical analyses
Conditional logistic regression analysis was performed with SAS PHREG pro-
cedure. Odds ratios were estimated for each septile of WHO-TEq. All analyses
were adjusted for sex. Several variables collected with the questionnaire were
used as confounders in the analysis one by one. Non-binary variables were ana-
lyzed as quartiles. 
Exposure to the following chemicals was asked as a binary variable: solvents,
solvent-based paints, formaldehyde, insecticides, fungicides/herbicides, wood
preservatives, strong detergents, heavy metals, and other chemicals.
FIGURE 1  Fractions of PCB-TEqs of the total TEq of PCDD/Fs and PCBs. Each point represents
one individual in the study.
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RESULTS
Contribution of PCB-TEqs to total WHO-TEq was similar in all age groups,
about 20 % on average (Fig. 1). On the other hand, individual variation was
large, and PCB contribution was from 1 % to 57 %. The range of total TEq val-
ues was from 4.6 to 197.8 ng/kg (in fat). There was high correlation between
PCB-TEq and PCDD/F-TEq (Pearson correlation coefficient 0.84) and between
PCB-TEq and total WHO-TEq (r=0.91).  
The STS risk was higher in the lowest septile than in other septiles (Fig. 2.),
and the difference was significant in the second and the sixth septile. The odds
ratios (compared with the lowest septile) varied from 0.15 (95 % CI 0.04 – 0.6)
to 0.39 (95 % CI 0.12 – 1.27). When the analysis was performed with WHO-TEq
quintiles instead of septiles, the odds ratios were 1, 0.44 (0.18-1.09), 0.73 (0.29-
1.84), 0.40 (0.14-1.13), and 0.49 (0.16-1.49). The analysis was also calculated
using total WHO-TEq concentration as a continuous linear variable showing a
decreasing trend (OR 0.86 for an interquartile TEq increase of 33.32 ng/kg
[WHO-TEq in fat], 95 % CI 0.60 – 1.24). When the three PCB-compounds were
analyzed separately, the continuous linear variables were: PCB 77, 1.08 (0.93-
1.26); PCB 126, 0.92 (0.7-1.22); PCB 169, 0.93 (0.68-1.27), and the sum TEq of
all three PCBs 0.92 (0.69-1.23). 
The decrease in odds ratios was not abolished by any of the studied con-
founders (sex, age, education, body mass index, fish consumption, smoking,
alcohol consumption, town size, and chemical exposure) (Fig. 3). On the other
hand, including confounders in the analysis tended to cause the odds ratios to
decrease in more linear fashion than in the basic result, especially to straighten
the kink of the second septile. At the same time, however, the statistical signifi-
cance of decreased odds ratio disappeared in septile 2 (which was the most unsta-
ble septile) in most analyses and in septile 6 in some analyses. A continuous lin-
ear analysis including fish as a confounder showed a decrease (OR 0.83 for an
interquartile TEq increase, 95 % CI 0.53 – 1.30).
FIGURE 2  Odds ratios (95 % CI) for STS as a function of total TEq concentration in fat
(PCDD/F + PCB, presented as the median of each septile). The cases were individually matched
for area and age, and sex was controlled as confounder.
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The present results indicate that the previous analysis comprising only 17
PCDD/F congeners does not essentially change, when the non-ortho PCB con-
geners, which contribute most to the PCB-TEq are also included in the sum
analysis. The result adds to confidence that previously reported result between
dioxin-TEQ and decreased cancer risk of cancer is not confounded by the lev-
els of PCB. In the previous study each dioxin congener was also analyzed sepa-
rately, and a general trend was that the congeners contributing most to WHO-
TEq showed a result similar to the main analysis of sum TEq. In the present
study PCB 126 (which contributes most to PCB-Teq), and PCB 169 indicated
even alone the same trend of decreasing risk. It should be noted that the con-
centrations of all these compounds correlate with each other, since their
sources are in part similar.
The contemporary body burden is considered a good measure for lifelong
exposure to dioxins and PCB compounds. The half-life of TCDD is 7 to 8 years
(Poiger and Schlatter, 1986, Pirkle et al., 1989, Flesch-Janys et al., 1996) and this
means at a constant intake a cumulation of about 40 years before reaching steady
state. Because exposure is mainly from food (Liem et al., 2000), fairly stable
exposure can be assumed on an average, and considering the long half-life, the
present concentration means integration of exposures during at least 10-20
years, in most cases probably over the whole lifetime. Although different from
congener to congener, elimination half-lives of all dioxins and PCBs are very
long, and such integration can be assumed to hold for WHO-TEqs as well.
Present exposure in Finland is mainly from Baltic fish, up to over 80%
(Kiviranta et al. 2001), although during previous decades also meat and dairy
products contributed to some extent (Hallikainen and Vartiainen, 1997).
Because fish consumption varies from person to person, this could be assumed
FIGURE 3  Odds ratios as a function of total TEq concentration (presented as the median of each
septile). Each line represents an analysis with a different confounder.
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to be one of the major differences causing variation in dioxin and PCB levels in
different people. An obvious hypothesis then could be that fish consumption
might decrease cancer risk, and cause the decreasing trend observed. However,
if fish consumption was added to the analysis as a confounder, the main result
did not change. Interestingly the analysis improved in the sense that the decrease
associated with increasing dioxin TEqs became more regular and linear. These
issues require further scrutinizing.
In animal studies, TCDD is a clear carcinogen in several species at high doses
(Kociba et al., 1978, Pitot et al., 1987, NTP 1982, Goodman and Sauer, 1992).
However, a tendency of less tumors or altered hepatic foci (indicating a carcino-
genic process) were seen in animals given low doses of TCDD (ca. 1 ng / kg body
weight / day), than were present in the controls in several studies (Kociba et al.,
FIGURE 4  Comparison of risk ratios from a chronic rat carcinogenicity bioassay (Kociba et al.,
1978, A is only hepatocellular carcinomas in female rats, B is hepatocellular carcinomas, hepatocel-
lular hyperplastic nodules, and bile duct adenomas), two tumor promotion assays (Pitot et al.,
1987; Viluksela et al., 2000, two rat strains, sensitive Long-Evans and resistant Han/Wistar) and the
present study. Abscissa is the measured TCDD (Kociba et al., 1978) or TEq (the present study) con-
centration in adipose tissue. For the data of Pitot et al. the same concentrations after the same
doses were assumed as given by Kociba et al., the lowest dose (0.1 ng/kg/d) was assumed to cause
one tenth of that after the lowest dose measured by Kociba et al. (1 ng/kg/d). Also the risk of soft
tissue sarcoma given by Steenland et al. (1999) is given at two levels, the whole subcohort of meas-
ured values (233 ng/kg fat; Fingerhut et al., 1991) backcalculated at 2000 ng/kg (Steenland et al.,
1999), and the high-exposure subgroup (418 ng/kg fat; Fingerhut et al., 1991) approximated by us
at 6000 ng/kg. These backcalculations may include a major error, if half-life after a high exposure
is much shorter than assumed (Aylward et al., 2005). This error would mean higher actual concen-
trations at the end of exposure, and move the points to the right even by one order of magnitude
or more.
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1978, Pitot et al., 1987, Viluksela et al., 2000). This dose would lead to a TCDD
concentration in rats of approximately 100 – 500 ng/kg (TCDD in fat) (Kociba
et al., 1978, Viluksela et al., 2000). This matches with the higher end of the
human concentrations in the present study (Fig. 4).
Andersen and Conolly (1998) have suggested a mechanistic model to
explain the U-shaped dose-response in liver tumors described by Pitot et al.
(1987). The model assumes that some (but not all) of the mutated cells are sen-
sitive to the mitoinhibitory effect of TCDD, resulting in a decrease in the num-
ber of mutated cells at low doses. Further studies to scrutinize such mechanisms
are urgently needed.
It may also be worthwhile to note that the non-induced activity of some CYP
enzymes, notably CYP1A1, is very low (Whitlock 1999). A slight induction could
be expected to facilitate the metabolism of many xenobiotics including carcino-
genic polycyclic hydrocarbons. Depending on the relative activity of the next
stage of metabolism, and possible interactions of dioxins with phase II conjuga-
tion reactions (cf. Nguyen et al., 2003), clearance of such compounds could then
be increased and their chances of acting as cancer initiators would be decreased.
In conclusion, the previously reported increased risk of STS at the lowest
levels of WHO-TEq was maintained when three most important dioxin-like
PCBs were included in the analysis. The provocative result within the present
population levels of dioxin exposure challenges the present carcinogenicity
estimates based on linear extrapolation from high to low doses. The existence
of a true J-shape dose-response curve in carcinogenesis by dioxin-like com-
pounds requires more scrutiny, but there are biologically plausible reasons to
consider this possibility.
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